ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9789
-1.01%
Brent Oil
83.54
-2.74%
Bitcoin
57,989.43
-4.31%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) Noticias

BPTH Bio Path Holdings Inc

2.76
-0.07 (-2.47%)
Fuera de horario
Última actualización: 15:14:08
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bio Path Holdings Inc BPTH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.07 -2.47% 2.76 15:14:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.77 2.61 2.80 2.76 2.83
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202411:14GLOBEBio-Path Holdings, Inc. Announces Closing of $1.2 Million..
18/4/202412:57GLOBEBio-Path Holdings, Inc. Announces $1.2 Million Registered..
18/4/202406:00GLOBEBio-Path Holdings Announces Successful Completion of Higher..
15/4/202406:00GLOBEBio-Path Holdings Expands Global Patent Portfolio
02/4/202406:00GLOBEBio-Path Holdings Provides 2024 Clinical and Operational..
11/3/202406:00EDGAR2Form 8-K - Current report
08/3/202416:11EDGAR2Form S-1 - General form for registration of securities under..
08/3/202406:10EDGAR2Form 8-K - Current report
08/3/202406:00GLOBEBio-Path Holdings Reports Full Year 2023 Financial Results
08/3/202405:22IHMARKETNEWSU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil..
07/3/202415:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202406:00GLOBEBio-Path Holdings to Announce Fourth Quarter and Full Year..
29/2/202405:00EDGAR2Form RW - Registration Withdrawal Request
23/2/202406:01EDGAR2Form 8-K - Current report
21/2/202406:00GLOBEBio-Path Holdings Announces 1-for-20 Reverse Stock Split
02/2/202415:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202415:10EDGAR2Form 8-K - Current report
23/1/202416:20EDGAR2Form 8-K - Current report
23/1/202415:51EDGAR2Form S-1/A - General form for registration of securities..
17/1/202415:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/1/202415:10EDGAR2Form 8-K - Current report
10/1/202406:00GLOBEBio-Path Holdings Announces Completion of First Dose Cohort..
04/1/202416:18EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202315:06EDGAR2Form PRE 14A - Other preliminary proxy statements
22/12/202315:05EDGAR2Form S-1 - General form for registration of securities under..
15/12/202315:05EDGAR2Form 8-K - Current report
14/12/202315:05EDGAR2Form 8-K - Current report
14/12/202306:00GLOBEBio-Path Holdings Successfully Completes First Dose Cohort..
08/12/202315:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/12/202315:05EDGAR2Form 8-K - Current report
15/11/202306:30EDGAR2Form 8-K - Current report
15/11/202306:00GLOBEBio-Path Holdings Reports Third Quarter 2023 Financial..
08/11/202306:00GLOBEBio-Path Holdings to Announce Third Quarter 2023 Financial..
27/10/202315:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/10/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202315:30EDGAR2Form 8-K - Current report
24/10/202306:00GLOBEBio-Path Holdings to Host Virtual Key Opinion Leader Event..
15/9/202315:30EDGAR2Form 8-K - Current report
08/9/202315:01GLOBEBio-Path Holdings to Present at H.C. Wainwright 25th Annual..
15/8/202306:10EDGAR2Form 8-K - Current report
15/8/202306:00GLOBEBio-Path Holdings Reports Second Quarter 2023 Financial..
14/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:00GLOBEBio-Path Holdings to Announce Second Quarter 2023 Financial..
07/8/202315:42EDGAR2Form 8-K - Current report
07/8/202306:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/8/202306:16EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
03/8/202307:22GLOBEBio-Path Holdings, Inc. Announces Pricing of $2.1 Million..
02/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
01/8/202316:02EDGAR2Form 8-K - Current report
01/8/202315:05EDGAR2Form S-1/A - General form for registration of securities..

Su Consulta Reciente

NASDAQ
BPTH
Bio Path
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados